Shehzad Batliwala, DO
Ophthalmology · Tulsa, OKNPI 1174054860
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Glaukos Corporation at 57.4% of the total. 2025 is the largest year on record at $6,770, 4.0 times the $1,698 reported in 2019. Among ophthalmology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 138 payments — averaging $76.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$6K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
- AbbVie$781
- Alcon$628
- Ocular Therapeutix, Inc.$354
- Sight Sciences, Inc.$263
- plus $1K from 12 others
What the payments were for
- Consulting fees$4,88846%
- Travel & lodging$1,28812%
- Food & beverage$4,43642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 13 | $6,092 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 13 | $1,478 |
| AbbVie | 44 | $781 |
| Alcon | 14 | $628 |
| Ocular Therapeutix, Inc. | 15 | $354 |
| Sight Sciences, Inc. | 15 | $263 |
| Biotissue Holdings Inc. | 2 | $238 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $187 |
| Amgen(2 entities) | 5 | $172 |
| Rxsight Inc | 4 | $131 |
| Genentech USA, Inc. | 1 | $119 |
| Nova Eye, Inc. | 1 | $60 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Lensar, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Oyster Point Pharma, Inc. | 1 | $14 |
| Rayner Intraocular Lenses Limited | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Travoprost Intraocular Implant - iDose$5,520
- STELLARIS PC$1,128
- CRYSTALENS$1,128
- AKREOS AO$1,128
- ENVISTA$1,128
- TRULIGN TORIC$1,128
- Prokera$238
- AmnioGraft$238
- iDoseTR$214
- Hydrus Microstent$131
- DEXTENZA$125
- VABYSMO$119
- ENVISTA TORIC$107
- TEPEZZA$104
How this compares
$10,612 in reported general payments places this provider in the 95th percentile of 183 ophthalmology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 123 | $5,464 |
| MoxifloxacinMoxifloxacin Hcl | 94 | $1,722 |
| Ketorolac Tromethamine | 82 | $1,130 |
| Latanoprost | 43 | $302 |
| Brimonidine Tartrate | 17 | $202 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Tulsa
- Thomas FinleyTulsa$9K
- Jamal SiddiquiTulsa$7K
- Kelli DyerTulsa$6K
- Lars FreisbergTulsa$6K
- Neha SangalTulsa$5K
- Thomas BriggsTulsa$4K
- Marc GoldbergTulsa$4K
- Daniel LangleyTulsa$3K
- Mark AllisonTulsa$3K
- Justin ParschauerTulsa$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.